![Ian Walters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Walters
Director Ejecutivo en
SalvaRx Ltd.
.
Perfil
Fundador de SalvaRx Group Plc, Ian B. Walters es actualmente director general y consejero de Portage Biotech, Inc. y director general y consejero de iOX Therapeutics Ltd. (filial de Portage Biotech, Inc.). (una filial de Portage Biotech, Inc.) y Director Médico y Vicepresidente de Intensity Therapeutics, Inc. Ian B. Walters también forma parte del consejo de administración de Enzo Biochem, Inc. y RIFT biotherapeutics, Inc. En su trayectoria profesional anterior fue director general de SalvaRx Group Plc, vicepresidente senior de medicina translacional y desarrollo corporativo en Sorrento Therapeutics, Inc. y miembro de Bristol-Myers Squibb Canada Co. Se doctoró en el Albert Einstein College of Medicine, Inc. y obtuvo un MBA en The Wharton School of the University of Pennsylvania.
Cargos activos de Ian Walters
| Empresas | Cargo | Inicio |
|---|---|---|
iOx Therapeutics Ltd.
 iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Director/Miembro de la Junta | 01/07/2015 |
Stimunity SAS
 Stimunity SAS BiotechnologyHealth Technology Provides biotechnology services | Presidente | - |
SalvaRx Ltd.
 SalvaRx Ltd. BiotechnologyHealth Technology Develops therapies in immuno-oncology market | Director Ejecutivo | - |
Antiguos cargos conocidos de Ian Walters.
| Empresas | Cargo | Fin |
|---|---|---|
| ALPHA COMPUTE CORP | Director Ejecutivo | 14/12/2024 |
| INTENSITY THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/08/2023 |
| SALVARX GROUP PLC | Fundador | 08/01/2019 |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Specializes in the research, development and manufacturing of oncology, immunology, hematology and cardiovascular diseases | Director de Operaciones | 01/03/2014 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Director Técnico/Científico/I+D | - |
Formación de Ian Walters.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
77
Relaciones de 1er grado
15
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 15 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Enzo Biochem, Inc.
 Enzo Biochem, Inc. BiotechnologyHealth Technology Provides enabling life science technologies for research, drug discovery, drug development and diagnostic solutions | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
AlphaTON Capital Corp.
 AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
3Legs Resources Plc
 3Legs Resources Plc Financial ConglomeratesFinance Invests in acquired companies within the technology sector | Finance |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Specializes in the research, development and manufacturing of oncology, immunology, hematology and cardiovascular diseases | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SalvaRx Ltd.
SalvaRx Ltd. BiotechnologyHealth Technology Develops therapies in immuno-oncology market | Health Technology |
iOx Therapeutics Ltd.
iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Health Technology |
SalvaRx Group Plc
 SalvaRx Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company that focuses on immune-oncology & invests in novel cancer immune-therapies | Commercial Services |
RIFT biotherapeutics, Inc.
 RIFT biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibodies for use in oncology | Commercial Services |
Stimunity SAS
Stimunity SAS BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
- Bolsa de valores
- Insiders
- Ian Walters
